Akebia Therapeutics (AKBA) Market Capitalization (2014 - 2026)
Akebia Therapeutics (AKBA) reported Market Capitalization of $309.79 million for Q2 2026, down 67.6% from $957.47 million a year earlier and down 16.8% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Market Capitalization (2014 - 2026) Analysis & Trends
For FY2025, Akebia Therapeutics posted Market Capitalization of $427.33 million, unchanged from FY2024.
- Market Capitalization has a five-year compound annual growth rate of 0.6% (FY2020 to FY2025).
- By year, Market Capitalization came in at $427.21 million in FY2024 (+77.1%), $241.28 million in FY2023 (+125.9%), $106.8 million in FY2022 (-73.3%) and $400.02 million in FY2021 (-3.5%).
- The Q2 2026 figure ranks as the lowest quarterly Market Capitalization since Q3 2024.
- Year over year, Market Capitalization gained in five of the last eight quarters, with growth averaging 68.9%.
- The high point for year-over-year Market Capitalization in five years was Q2 2025 (growth of 347.2%); the low point was Q2 2022 (a decline of 90.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $372.38 million (Q1 2026), $427.33 million (Q4 2025) and $724.07 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Akebia Therapeutics | 241.85 Mn | -427.63 Mn | 38.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 309.79 Mn |
| Mar 31, 2026 | 372.38 Mn |
| Dec 31, 2025 | 427.33 Mn |
| Sep 30, 2025 | 724.07 Mn |
| Jun 30, 2025 | 957.47 Mn |
| Mar 31, 2025 | 502.36 Mn |
| Dec 31, 2024 | 427.21 Mn |
| Sep 30, 2024 | 279.24 Mn |
| Jun 30, 2024 | 214.13 Mn |
| Mar 31, 2024 | 383.30 Mn |
| Dec 31, 2023 | 241.28 Mn |
| Sep 30, 2023 | 214.68 Mn |
| Jun 30, 2023 | 173.08 Mn |
| Mar 31, 2023 | 104.07 Mn |
| Dec 31, 2022 | 106.80 Mn |
| Sep 30, 2022 | 58.86 Mn |
| Jun 30, 2022 | 64.30 Mn |
| Mar 31, 2022 | 132.04 Mn |
| Dec 31, 2021 | 400.02 Mn |
| Sep 30, 2021 | 502.71 Mn |
API Access
Akebia Therapeutics Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();